Objects
Loo, Sun, Roberts, Andrew W., Taper, John, Cull, Gavin, Tiley, Campbell, Verner, Emma, Hahn, Uwe, Hiwase, Devendra K., Iland, Harry J., Murphy, Nick, Ramanathan, Sundra, Reynolds, John, Anstee, Natasha S., Ong, DM, Tiong, IS, Wall, M, Murray, M, Rawling, T, Leadbetter, J, Rowley, L, Latimer, M, Yuen, SLS, Ting, SB, Kennedy, Glen A., Fong, CY, Morris, KL, Bajel, A, Seymour, JF, Levis, MJ, Wei, AH, He, Simon, Schwarer, Anthony P., Enjeti, Anoop K., D'Rozario, James, Marlton, Paula, Bilmon, Ian A.. American Society of Hematology; 2023. Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Lau, Colleen L., Mayfield, Helen J., Sinclair, Jane E., Brown, Samuel J., Waller, Michael, Enjeti, Anoop K., Baird, Andrew, Short, Kirsty R., Mengersen, Kerrie, Litt, John. Elsevier; 2021. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
Hunt, Kooper V., Burnard, Sean M., Roper, Ellise A., Bond, Danielle R., Dun, Matthew D., Verrills, Nicole M., Enjeti, Anoop K., Lee, Heather J.. Nature Publishing Group; 2022. scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs.
Berry, Nadine K., Scott, Rodney J., Sutton, Rosemary, Law, Tamara, Trahair, Toby N., Dalla-Pozza, Luce, Ritchie, Petra, Barbaric, Draga, Enjeti, Anoop K.. Elsevier; 2020. Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort.
Dun, Matthew D., Mannan, Abdul, Germon, Zacary, Faulkner, Sam, Chi, Mengna, Skerrett-Byrne, David, Murray, Heather C., Flanagan, Hayley, Almazi, Juhura G., Hondermarck, Hubert, Nixon, Brett, De Iuliis, Geoff, Rigby, Callum J., Chamberlain, J, Alvaro, F, de Bock, CE, Morris, JC, Enjeti, Anoop K., Verrills, Nicole M., Butler, Stephen, Toop, Hamish D., Beck, Dominik, Connerty, Patrick, Sillar, Jonathan, Kahl, Richard G. S., Duchatel, Ryan J.. Nature Publishing Group; 2020. Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia.
Campbell, Ashlea, Teh, Benjamin, Lane, Steven, Dickinson, Michael, Quach, Hang, Enjeti, Anoop K., Ku, Matthew, Gregory, Gareth, Hapgood, Gregory, Ho, Phoebe Joy, Cochrane, Tara, Cheah, Chan, Mulligan, Stephen, Greenwood, Matthew, Latimer, M, Berkahn, L, Wight, J, Armytage, T, Diamond, P, Tam, CS, Hamad, N, Ross, David M., Weinkove, Robert, Gilroy, Nicole, Gangatharan, Shane, Prince, Henry Miles, Szer, Jeff, Trotman, Judith. John Wiley & Sons; 2023. Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.
Germon, Zacary P., Sillar, Jonathan R., McLachlan, Tabitha, Schjenken, John E., Skerrett-Byrne, David A., Huang, Honggang, Melo-Braga, Marcella N., Plank, Maximillan W., Alvaro, Frank, Chamberlain, Janis, De Iuliis, Geoff, Aitken, R. John, Mannan, Abdul, Nixon, Brett, Wei, AH, Enjeti, Anoop K., Huang, Y, Lock, RB, Larsen, MR, Lee, Heather, Vaghjiani, V, Cain, JE, de Bock, CE, Duchatel, Ryan J., Verrills, Nicole M., Dun, Matthew D., Staudt, Dilana, Murray, Heather C., Findlay, Izac J., Jackson, Evangeline R., McEwen, Holly P., Douglas, Alicia M.. American Association for the Advancement of Science (AAAS); 2023. Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.
Lim, Ming Sheng, Ariyarajah, Anita, Oldmeadow, Christopher, Hall, Alix, Enjeti, Anoop K.. Thieme Medical Publishers; 2017. A systematic review and meta-analysis comparing anticoagulation versus no anticoagulation and shorter versus longer duration of anticoagulation for treatment of isolated distal deep vein thrombosis.
Enjeti, Anoop K., Agarwal, Rishu, Singhal, Deepak, Tate, Courtney, Tiong, Ing Soo, Ross, David M., Blombery, Piers, Chee, Lynette, Chua, Chong Chyn, Grigg, Andrew, Hamad, Nada, Iland, Harry, Lane, Steven, Perkins, Andrew. Elsevier; 2022. Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.
Lincz, Lisa F., Theron, Danielle Z., Barry, Daniel L., Scorgie, Fiona E., Sillar, Jonathan, Sefhore, Opelo, Enjeti, Anoop K., Skelding, Kathryn A.. MDPI AG; 2024. High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia.
Lincz, Lisa F., Makhija, Karan, Attalla, Khaled, Scorgie, Fiona E., Enjeti, Anoop K., Prasad, Ritam. Wiley-Blackwell; 2024. A comparative evaluation of three consecutive artificial intelligence algorithms released by Techcyte for identification of blasts and white blood cells in abnormal peripheral blood films.
Ho, P. Joy, Spencer, Andrew, Mollee, Peter, Bryant, Christian E., Enjeti, Anoop K., Horvath, Noemi, Butcher, Belinda E., Trotman, Judith, Gibbs, Simon, Joshua, Douglas E.. Elsevier; 2024. Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment—An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse.
McCaughan, Georgia, Di Ciaccio, Pietro, Ross, David M., Mulligan, Stephen, Trotman, Judith, Dickinson, Michael, Quach, Hang, Choi, Phillip, Polizzotto, Mark N., Tam, Constantine S., Ho, P. Joy, Ku, Matthew, Ananda-Rajah, Michelle, Gregory, Gareth, Gangatharan, S, Hapgood, G, Cochrane, T, Cheah, C, Gibbs, S, Wei, A, Johnston, A, Greenwood, M, Prince, HM, Gilroy, Nicole, Latimer, M, Berkahn, L, Wight, J, Armytage, T, Hamad, N, MacIntyre, Raina, Teh, Benjamin, Weinkove, Robert, Curnow, Jennifer, Szer, Jeff, Enjeti, Anoop K.. Wiley-Blackwell; 2021. COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
Enjeti, Anoop K., Fogler, William E., Smith, Theodore A. G., Lincz, Lisa F., Bond, Danielle R., Magnani, John L.. Wiley-Blackwell Publishing; 2024. Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.